These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2361017)

  • 1. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
    Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
    Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
    Senaldi G; Lupoli S; Vergani D; Black CM
    Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways to complement activation during cardiopulmonary bypass.
    Collett B; Alhaq A; Abdullah NB; Korjtsas L; Ware RJ; Dodd NJ; Alimo E; Ponte J; Vergani D
    Br Med J (Clin Res Ed); 1984 Nov; 289(6454):1251-4. PubMed ID: 6437506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of complement activation during bypass by prime manipulation.
    Bonser RS; Dave JR; Davies ET; John L; Taylor P; Gaya H; Lennox SC; Vergani D
    Ann Thorac Surg; 1990 Feb; 49(2):279-83. PubMed ID: 2306150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation during cardiopulmonary bypass by heparin-protamine interaction.
    Best N; Sinosich MJ; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1984 Apr; 56(4):339-43. PubMed ID: 6608952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation by cellulosic dialysis membranes.
    Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
    J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative changes in complement associated with cardiopulmonary bypass.
    Boralessa H; Shifferli JA; Zaimi F; Watts E; Whitwam JG; Rees AJ
    Br J Anaesth; 1982 Oct; 54(10):1047-52. PubMed ID: 6982053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways.
    Jones HM; Matthews N; Vaughan RS; Stark JM
    Anaesthesia; 1982 Jun; 37(6):629-33. PubMed ID: 6920244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
    Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
    Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
    Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
    Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
    Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in C3, C4, factor B, and related metabolites in septic shock.
    Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
    Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration.
    Chiu RC; Samson R
    Ann Thorac Surg; 1984 Mar; 37(3):229-32. PubMed ID: 6703805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.